Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
89pct
63d open
vs 10,940 other HR bills in the 119th — cohort avg 30d
Advancing Cutting Edge Agriculture Act or the ACE Agriculture Act This bill reauthorizes the Agriculture Advanced Research and Development Authority (AGARDA) through FY2032 and expands the program's environmental sustainability goals. This Department of Agriculture (USDA) program supports innovative research and development of technology, research tools, and products to address long-term and high-risk challenges related to food and agriculture. The bill expands the program's goals to include water conservation; responding to greenhouse gas emissions; and resilience to drought, infectious diseases, and plant and animal pathogens and pests. The bill also expands the program's goals to include undertaking advanced research and development in areas in which industry by itself is not likely to do so because of economic cost. Further, the bill removes the current pilot program designation and requires USDA to establish and maintain an AGARDA staff. Finally, the bill allows USDA to use any unobligated USDA funds to implement the program.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2026 · first_quarter · Utilities
General issues related to electric utility operations; discussions related to infrastructure permitting reforms; general issues involving commercial nuclear policy interests, and LIHEAP issues as included in FY26 appropriations bills - Energy and Water Development (HR 4553 and S. 3293) and Labor HHS (HR 5304 and S. 2587) later combined in HR 6938 - FY2026 Consolidated CJS, Energy & Water, Interior Appropriations Act and HR 7142 - FY2026 Consolidated Defense, LHHSED, Nat. Sec.-State, THUD, FSGG Approps. Act; DOE implementation of electric utility-related issues in H.R. 1 - the One Big Beautiful Bill
Referred to the Subcommittee on Conservation, Research, and Biotechnology.
Referred to the House Committee on Agriculture.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $80,000
Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Health Issues
Patient access to rare and orphan disease therapeutics; FDA regulatory pathways for pharmaceuticals; Awareness of Cystic Fibrosis and Sickle Cell Disease; Education about non-opioid pain therapies and Medicare beneficiary access to non-opioid medicines; HR 7142 and S. 3832
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Health Issues
Patient access to rare and orphan disease therapeutics; FDA regulatory pathways for pharmaceuticals; Awareness of Cystic Fibrosis and Sickle Cell Disease; Education about non-opioid pain therapies and Medicare beneficiary access to non-opioid medicines; HR 7142 and S. 3832
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Health Issues
Patient access to rare and orphan disease therapeutics; FDA regulatory pathways for pharmaceuticals; Awareness of Cystic Fibrosis and Sickle Cell Disease; Education about non-opioid pain therapies and Medicare beneficiary access to non-opioid medicines; HR 7142 and S. 3832
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Health Issues
Patient access to rare and orphan disease therapeutics; FDA regulatory pathways for pharmaceuticals; Awareness of Cystic Fibrosis and Sickle Cell Disease; Education about non-opioid pain therapies and Medicare beneficiary access to non-opioid medicines; HR 7142 and S. 3832
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE